Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arbutus Biopharma | ABUS | Nov 25, 2024 | 3.42 | -2.56 |
ARC Document Solutions | ARC | Nov 25, 2024 | 3.39 | 0.00 |
Arcadia Biosciences | RKDA | Nov 25, 2024 | 2.76 | +0.73 |
Arcadium Lithium | ALTM | Nov 25, 2024 | 5.32 | +0.57 |
ArcBest | ARCB | Nov 25, 2024 | 112.58 | +2.43 |
Arcellx | ACLX | Nov 25, 2024 | 89.41 | -1.14 |
Arcelor Mittal ADR | MT | Nov 25, 2024 | 24.86 | -1.00 |
Arch Capital F Pref | ACGLO | Nov 25, 2024 | 22.87 | -0.15 |
Arch Capital G | ACGLN | Nov 25, 2024 | 19.91 | -0.35 |
Arch Capital Group | ACGL | Nov 25, 2024 | 100.06 | +0.37 |
Arch Resources A | ARCH | Nov 25, 2024 | 175.55 | +1.10 |
Archer Aviation A | ACHR | Nov 25, 2024 | 7.48 | +23.84 |
Archer Daniels Midland | ADM | Nov 25, 2024 | 53.01 | -0.23 |
Archrock | AROC | Nov 25, 2024 | 25.38 | -1.86 |
Arcos Dorados | ARCO | Nov 25, 2024 | 8.43 | +0.36 |
Arcosa | ACA | Nov 25, 2024 | 111.57 | +0.90 |
Arcturus Therapeutics | ARCT | Nov 25, 2024 | 17.58 | +3.96 |
Arcus Biosciences | RCUS | Nov 25, 2024 | 14.56 | -0.95 |
Arcutis Biotherapeutics | ARQT | Nov 25, 2024 | 10.77 | +6.21 |
Ardagh Metal Packaging | AMBP | Nov 25, 2024 | 3.71 | -0.54 |
Ardelyx | ARDX | Nov 25, 2024 | 5.25 | -1.13 |
Ardent Health Partners | ARDT | Nov 25, 2024 | 16.41 | +3.66 |
Ardmore Shipping | ASC | Nov 25, 2024 | 11.84 | -0.08 |
Ares Acquisition II | AACT | Nov 25, 2024 | 10.90 | 0.00 |
Ares Capital | ARCC | Nov 25, 2024 | 22.00 | -0.09 |
Ares Commercial Real Estate | ACRE | Nov 25, 2024 | 7.29 | +2.39 |
Ares Dynamic Credit Allocation Fund | ARDC | Nov 25, 2024 | 15.25 | -0.13 |
Ares Management A | ARES | Nov 25, 2024 | 176.03 | +0.29 |
Ares Management Pref B | ARES-B | Nov 25, 2024 | 55.57 | 0.00 |
Argan | AGX | Nov 25, 2024 | 157.02 | -1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.